In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Aromasin, Exemestane Drug Master File in Korea (Aromasin, Exemestane KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Aromasin, Exemestane. The MFDS reviews the Aromasin, Exemestane KDMF as part of the drug registration process and uses the information provided in the Aromasin, Exemestane KDMF to evaluate the safety and efficacy of the drug.
After submitting a Aromasin, Exemestane KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Aromasin, Exemestane API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Aromasin, Exemestane suppliers with KDMF on PharmaCompass.